FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA approved a supplemental application for NOVOLIN 70/30 (human insulin) from Novo Nordisk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• NOVOLIN 70/30 (HUMAN INSULIN)

Snippet

SUPPL AP for NOVOLIN 70/30 (HUMAN INSULIN)